Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Fara, Petruzziello"'
Autor:
Raffaele Sessa, Silvia Trombetti, Alessandra Lo Bianco, Giovanni Amendola, Rosa Catapano, Elena Cesaro, Fara Petruzziello, Maria D'Armiento, Giuseppe Maria Maruotti, Giuseppe Menna, Paola Izzo, Michela Grosso
Publikováno v:
Open Biology, Vol 14, Iss 2 (2024)
Transient abnormal myelopoiesis (TAM) is a Down syndrome-related pre-leukaemic condition characterized by somatic mutations in the haematopoietic transcription factor GATA-1 that result in exclusive production of its shorter isoform (GATA-1S). Given
Externí odkaz:
https://doaj.org/article/25d54d82a9fd49ac80e2cfb705873602
Autor:
Giovanna Giagnuolo, Salvatore Buffardi, Francesca Rossi, Fara Petruzziello, Chiara Tortora, Isabella Buffardi, Nicoletta Marra, Giuliana Beneduce, Giuseppe Menna, Rosanna Parasole
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0215295 (2019)
Chemotherapy-induced nausea and vomiting (CINV) is a distressing treatment side-effect that could negatively affect children's quality of life (QoL). Different scoring systems for CINV were applied and different antiemetic drugs were used; however, f
Externí odkaz:
https://doaj.org/article/6fb725384eb94f03bde3e3700ddd1dcc
Autor:
Luciana Vinti, Daria Pagliara, Salvatore Buffardi, Valentina Di Ruscio, Francesca Stocchi, Elena Mariggiò, Rosanna Parasole, Antonia De Matteo, Fara Petruzziello, Valeria Paganelli, Rita De Vito, Francesca Del Bufalo, Luisa Strocchio, Franco Locatelli
Although children and young adults with Hodgkin's lymphoma usually have a favorable prognosis, patients with primary refractory disease and some subsets of relapsed patients still have a dismal outcome. Brentuximab vedotin (BV) in combination with be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f2638000bab5f81dffc8d9dfe913ba8
https://hdl.handle.net/10807/228292
https://hdl.handle.net/10807/228292
Autor:
Matteo Luciani, Anna Maria Testi, Concetta Micalizzi, Silvio Tafuri, Carmelo Rizzari, Nicola Santoro, Maria C. Putti, Caterina Consarino, Paola Giordano, Berardino Pollio, Antonella Colombini, Lucia Dora Notarangelo, Elena Mastrodicasa, Paola Carmela Corallo, Fara Petruzziello, Fiorina Casale, Rosa M. Mura, Daniela Onofrillo, Francesco De Leonardis, Paola Saracco, Massimo Grassi
Publikováno v:
Journal of Pediatric Hematology/Oncology. 41:275-279
Objective of the Study:In this study we aimed to retrospectively evaluate how centers, belonging to the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP), manage severe acquired hypofibrinogenemia in children with acute lymphoblastic le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1781b99f707b997cd77e3f9b250423bc
https://doi.org/10.1097/mph.0000000000001390
https://doi.org/10.1097/mph.0000000000001390
Autor:
Argia Mangione, Antonia De Matteo, Antonio Del Puente, Giovanna Giagnuolo, Giuseppe Menna, Antonella Esposito, Fara Petruzziello, Rosanna Parasole
Publikováno v:
Journal of Pediatric Hematology/Oncology. 41:140-144
Reduced bone mineral density (BMD) is a well-known complication in childhood acute lymphoblastic leukemia (ALL) survivors; the optimal method to assess BMD is still debated. We studied BMD by quantitative ultrasound (QUS) in 72 ALL survivors, and eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112821724e5081671d597a50a109c90a
https://doi.org/10.1097/mph.0000000000001146
https://doi.org/10.1097/mph.0000000000001146
Autor:
Giuliana Beneduce, Antonia De Matteo, Pio Stellato, Anna M. Testi, Nicoletta Bertorello, Antonella Colombini, Maria C. Putti, Carmelo Rizzari, Simone Cesaro, Monica Cellini, Elena Barisone, Fara Petruzziello, Giuseppe Menna, Rosanna Parasole
Publikováno v:
Europe PubMed Central
Cancers; Volume 14; Issue 2; Pages: 426
Cancers
Cancers, Vol 14, Iss 426, p 426 (2022)
Cancers; Volume 14; Issue 2; Pages: 426
Cancers
Cancers, Vol 14, Iss 426, p 426 (2022)
Simple Summary Blinatumomab, a bispecific T-cell engager, binding T-cell CD3 and B-cell CD19 antigens, has remarkably enlarged the treatment options for patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (r/r BCP-ALL). Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b4d056219925bd5491c38b59e8d96fa
https://doi.org/10.3390/cancers14020426
https://doi.org/10.3390/cancers14020426
Autor:
Franco Locatelli, Fiorina Giona, Maria Caterina Putti, Rosamaria Mura, Andrea Biondi, Concetta Micalizzi, Caterina Consarino, Nadia Vacca, Nicola Santoro, Grazia Iaria, Maria Luisa Moleti, Ottavio Ziino, Giuseppe Menna, Antonella Sau, Fara Petruzziello, Robin Foà, Roberta Burnelli, Saverio Ladogana, Michelina Santopietro, Sayla Bernasconi
Publikováno v:
Acta Haematologica. 140:105-111
Background: To date, no data on the adherence to specific guidelines for children with chronic myeloid leukemia (CML) in chronic phase (CP) have been reported. Methods: Since 2001, guidelines for treatment with imatinib mesylate (IM) and monitoring i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f18ebc5f40a9293facfaf58ed6a4c7ed
https://doi.org/10.1159/000491546
https://doi.org/10.1159/000491546
Autor:
Adele Bolognese, Anna Esposito, Michele Manfra, Lucio Catalano, Fara Petruzziello, Maria Carmen Martorelli, Raffaella Pagliuca, Vittoria Mazzarelli, Maria Ottiero, Melania Scalfaro, Bruno Rotoli
Publikováno v:
Advances in Hematology, Vol 2009 (2009)
The (R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl-boronic acid, bortezomib (BTZ), which binds the 20S proteasome subunit and causes a large inhibition of its activity, is a peptidomimetic boronic drug mainly used for the tr
Externí odkaz:
https://doaj.org/article/56a270b823624fecbb34ff9e7000f00c
Autor:
Patrizia Zappasodi, Erika Borlenghi, Maria Ilaria Del Principe, Cristina Papayannidis, Mario Luppi, Francesco Lanza, Fabio Ciceri, Alberto Clemente, Nicola Stefano Fracchiolla, Monica Fumagalli, Nicola Di Renzo, Paolo de Fabritiis, Fara Petruzziello, Chiara Zingaretti, Felicetto Ferrara, Elisabetta Todisco, Elisabetta Petracci, Fabrizio Pane, Francesco Passamonti, Daniele Mattei, Giovanni Martinelli, Giovanni Marconi, Francesco Di Raimondo, Daniele Vallisa, Giuseppe Nicola Saglio, Endri Mauro, Irene Valli, Paolo Corradini, Simona Sica, Antonino Mulè
Publikováno v:
Blood. 138:4391-4391
Background: Inotuzumab-ozogamicin (IO) is one of the drugs of choice for relapse/refractory (R/R) acute lymphoblastic leukemia (ALL). Patients who received IO in a clinical trial had a CR rate of approximately 81% and a median overall survival of app
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0987b3868e4de1a921b07f17aa6bc606
https://doi.org/10.1182/blood-2021-149157
https://doi.org/10.1182/blood-2021-149157
Autor:
Patrizia Riccio, Raffaele Sessa, Sergio de Nicola, Fara Petruzziello, Silvia Trombetti, Giuseppe Menna, Giampiero Pepe, Pasquale Maddalena, Paola Izzo, Michela Grosso
Publikováno v:
Journal of Cellular Physiology. 234
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::152a647c415def9dee73537d208a288c
https://doi.org/10.1002/jcp.29114
https://doi.org/10.1002/jcp.29114